231 related articles for article (PubMed ID: 31480539)
1. Hippocampus Metabolic Disturbance and Autophagy Deficiency in Olfactory Bulbectomized Rats and the Modulatory Effect of Fluoxetine.
Zhou Y; Tao X; Wang Z; Feng L; Wang L; Liu X; Pan R; Liao Y; Chang Q
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480539
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabolic disturbance in the olfactory bulbectomized rats and the modulatory effects of fluoxetine.
Zhou YF; Feng L; Liu XM; Tao X; Wang LS; Zhang MD; Wang Z; Chen SG; Chang Q
Life Sci; 2019 Oct; 234():116751. PubMed ID: 31415771
[TBL] [Abstract][Full Text] [Related]
3. The olfactory bulbectomized rat model is not an appropriate model for studying depression based on morphological/stereological studies of the hippocampus.
Yurttas C; Schmitz C; Turgut M; Strekalova T; Steinbusch HWM
Brain Res Bull; 2017 Sep; 134():128-135. PubMed ID: 28734903
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
Wang YQ; Tu ZC; Xu XY; Li R; Qu WM; Urade Y; Huang ZL
J Neurochem; 2012 Jan; 120(2):314-24. PubMed ID: 22035172
[TBL] [Abstract][Full Text] [Related]
5. Minocycline restores spatial but not fear memory in olfactory bulbectomized rats.
Borre Y; Sir V; de Kivit S; Westphal KG; Olivier B; Oosting RS
Eur J Pharmacol; 2012 Dec; 697(1-3):59-64. PubMed ID: 23051675
[TBL] [Abstract][Full Text] [Related]
6. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.
Bansal Y; Singh R; Saroj P; Sodhi RK; Kuhad A
Toxicol Appl Pharmacol; 2018 Sep; 355():257-268. PubMed ID: 30017640
[TBL] [Abstract][Full Text] [Related]
7. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
[TBL] [Abstract][Full Text] [Related]
8. Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.
Machado DG; Cunha MP; Neis VB; Balen GO; Colla AR; Grando J; Brocardo PS; Bettio LE; Dalmarco JB; Rial D; Prediger RD; Pizzolatti MG; Rodrigues AL
J Ethnopharmacol; 2012 Aug; 143(1):158-69. PubMed ID: 22721880
[TBL] [Abstract][Full Text] [Related]
9. The absence of 5-HT
Amigó J; Díaz A; Pilar-Cuéllar F; Vidal R; Martín A; Compan V; Pazos A; Castro E
Neuropharmacology; 2016 Dec; 111():47-58. PubMed ID: 27586007
[TBL] [Abstract][Full Text] [Related]
10. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL
Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581
[TBL] [Abstract][Full Text] [Related]
11. Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat.
Morales-Medina JC; Juarez I; Venancio-García E; Cabrera SN; Menard C; Yu W; Flores G; Mechawar N; Quirion R
Neuroscience; 2013 Apr; 236():233-43. PubMed ID: 23357118
[TBL] [Abstract][Full Text] [Related]
12. Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.
Jindal A; Mahesh R; Bhatt S
Psychopharmacology (Berl); 2015 Feb; 232(3):623-37. PubMed ID: 25120105
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice.
Freitas AE; Machado DG; Budni J; Neis VB; Balen GO; Lopes MW; de Souza LF; Dafre AL; Leal RB; Rodrigues AL
Behav Brain Res; 2013 Jan; 237():176-84. PubMed ID: 23018126
[TBL] [Abstract][Full Text] [Related]
14. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.
Hendriksen H; Meulendijks D; Douma TN; Bink DI; Breuer ME; Westphal KG; Olivier B; Oosting RS
Neuropharmacology; 2012 Jan; 62(1):270-7. PubMed ID: 21807004
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety.
Mar A; Spreekmeester E; Rochford J
Pharmacol Biochem Behav; 2002 Oct; 73(3):703-12. PubMed ID: 12151047
[TBL] [Abstract][Full Text] [Related]
16. Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.
Flores-Burgess A; Millón C; Gago B; García-Durán L; Cantero-García N; Puigcerver A; Narváez JA; Fuxe K; Santín L; Díaz-Cabiale Z
Int J Neuropsychopharmacol; 2022 Apr; 25(4):307-318. PubMed ID: 34891163
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression.
Borre YE; Panagaki T; Koelink PJ; Morgan ME; Hendriksen H; Garssen J; Kraneveld AD; Olivier B; Oosting RS
Neuropharmacology; 2014 Apr; 79():738-49. PubMed ID: 24286859
[TBL] [Abstract][Full Text] [Related]
18. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
[TBL] [Abstract][Full Text] [Related]
19. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
20. The olfactory bulbectomized rat as a model of depression: The hippocampal pathway.
Morales-Medina JC; Iannitti T; Freeman A; Caldwell HK
Behav Brain Res; 2017 Jan; 317():562-575. PubMed ID: 27633561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
